Influencing factors of good quality of life among chronic obstructive pulmonary disease patients living in Zhejiang Province, China

被引:0
|
作者
Ying, Yubing [1 ]
Khunthason, Siriyaporn [1 ]
Apidechkul, Tawatchai [1 ]
Nilvarangkul, Kessarawan [2 ]
机构
[1] Mae Fah Luang Univ, Sch Hlth Sci, 333 Moo 1, Muang Dist 57100, Chiang Rai Prov, Thailand
[2] Chiang Rai Rajabhat Univ, 80 Moo 9 Phaholyothin Rd, Muang Dist 57100, Chiang Rai, Thailand
关键词
COPD; Associated factors; SGRQ; Good QOL; COPD; COMORBIDITIES; EXACERBATION; DEPRESSION; BURDEN; PREVALENCE; MORTALITY; ANXIETY; HEALTH; RISK;
D O I
10.1038/s41598-024-59289-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a chronic, progressive and debilitating disease that affects quality of life (QOL), especially among patients living in poor environments. This study aimed to determine the influencing factors of good QOL among COPD patients living in Zhejiang, China. A cross-sectional study was conducted to collect data from participants in six tertiary hospitals in Zhejiang Province by a simple random sampling method. A validated questionnaire was used to collect general information, environmental factors, and COPD stage. The standardized St. George's Respiratory Questionnaire (SGRQ) was used to assess QOL. Logistic regression was used to determine influencing factors of good QOL among COPD patients at a significance level of alpha = 0.05. A total of 420 participants were recruited for analysis. The overall prevalence of patients with good QOL was 25.7%. Six variables were found to be associated with good QOL in the multivariable analysis. Patients who were employed had 2.35 times (95% CI 1.03-5.34) greater odds of having good QOL than those who were unemployed. Those whose family income was higher than 100,000 CNY had 2.49 times (95% CI 1.15-5.39) greater odds of having good QOL than those whose family income was lower than 100,000 CNY. Those who had treatment expenses less than 5,000 CNY had 4.57 (95% CI 1.57-13.30) times greater odds of having good QOL than those who had treatment expenses of 5,000 CNY or higher. Those who had mild or moderate airflow limitation were 5.27 times (95% CI 1.61-17.26) more likely to have good QOL than those who were in a severe or very severe stage of COPD. Those who had a duration of illness less than 60 months had 5.57 times (95% CI 1.40-22.12) greater odds of having good QOL than those who had a duration of illness of 120 months or more. Those who were not hospitalized within the past 3 months had 9.39 times (95% CI 1.62-54.43) greater odds of having good QOL than those who were hospitalized more than twice over the past 3 months. Socioeconomic status, disease stage and accessibility were associated with good QOL among COPD patients in Zhejiang Province, China. Increasing family income and implementing measures to improve the accessibility of medical care, including developing a proper system to decrease the cost of treatment for COPD patients, can improve patients' QOL.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Factors associated with the quality of life in patients with chronic obstructive pulmonary disease
    Villar Balboa, Ivan
    Carrillo Munoz, Ricard
    Regi Bosque, Meritxell
    Marzo Castillejo, Merce
    Arcusa Villacampa, Nuria
    Segundo Yaguee, Marta
    ATENCION PRIMARIA, 2014, 46 (04): : 179 - 187
  • [12] Dyadic coping, quality of life, and psychological distress among chronic obstructive pulmonary disease patients and their partners
    Meier, Caroline
    Bodenmann, Guy
    Moergeli, Hanspeter
    Jenewein, Josef
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 583 - 596
  • [13] The influence of adverse drug effects on health-related quality of life in chronic obstructive pulmonary disease patients
    Altawalbeh, Shoroq M.
    Almomani, Basima A.
    Alefan, Qais
    Momany, Suleiman Mohammad
    Al-Share, Qusai Y.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (05) : 457 - 465
  • [14] Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease
    Saiphoklang, Narongkorn
    Phadungwatthanachai, Jiranan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [15] Predictors of quality of life of patients with chronic obstructive pulmonary disease
    Vasiljevic, Sladjana
    Petrovic, Marina
    Cvetkovic, Aleksandra
    Paunovic, Vesna
    Mikic, Darko
    Radjen, Slavica
    VOJNOSANITETSKI PREGLED, 2019, 76 (07) : 716 - 722
  • [16] Risk Factors for Depression in Patients with Chronic Obstructive Pulmonary Disease
    Xu, Kang
    Li, Xiu
    MEDICAL SCIENCE MONITOR, 2018, 24 : 1417 - 1423
  • [17] Sex based differences in depression, anxiety, and quality of life and predictors of quality of life among South Asian individuals with chronic obstructive pulmonary disease: A Bayesian analysis
    Younas, Ahtisham
    Zeb, Hussan
    Durante, Angela
    Vellone, Ercole
    SOCIAL SCIENCE & MEDICINE, 2024, 351
  • [18] Sex based differences in depression, anxiety, and quality of life and predictors of quality of life among South Asian individuals with chronic obstructive pulmonary disease: A Bayesian analysis
    Younas, Ahtisham
    Zeb, Hussan
    Durante, Angela
    Vellone, Ercole
    SOCIAL SCIENCE & MEDICINE, 2024, 351
  • [19] Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease
    Mohsen, Shorouk
    Hanafy, Fadia Zaki
    Fathy, Aya Ahmed
    El-Gilany, Abdel-Hady
    LUNG INDIA, 2019, 36 (03) : 193 - 198
  • [20] Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease in China: Results from the China Pulmonary Health [CPH] Study
    Huang, Ke
    Huang, Kewu
    Xu, Jianying
    Yang, Lan
    Zhao, Jianping
    Zhang, Xiangyan
    Bai, Chunxue
    Kang, Jian
    Ran, Pixin
    Shen, Huahao
    Wen, Fuqiang
    Chen, Yahong
    Sun, Tieying
    Shan, Guangliang
    Lin, Yingxiang
    Wu, Sinan
    Yang, Ting
    Wang, Chen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 3387 - 3396